167 related articles for article (PubMed ID: 9811524)
1. Clearance of murine leukaemia virus from monoclonal antibody solution by a hydrophilic PVDF microporous membrane filter.
Aranha-Creado H; Peterson J; Huang PY
Biologicals; 1998 Jun; 26(2):167-72. PubMed ID: 9811524
[TBL] [Abstract][Full Text] [Related]
2. Membrane filtration for virus removal.
Brandwein H; Aranha-Creado H
Dev Biol (Basel); 2000; 102():157-63. PubMed ID: 10794103
[TBL] [Abstract][Full Text] [Related]
3. The use of a microporous polyvinylidene fluoride (PVDF) membrane filter to separate contaminating viral particles from biologically important proteins.
Oshima KH; Evans-Strickfaden TT; Highsmith AK; Ades EW
Biologicals; 1996 Jun; 24(2):137-45. PubMed ID: 8889061
[TBL] [Abstract][Full Text] [Related]
4. Real time quantitative PCR as a method to evaluate xenotropic murine leukemia virus removal during pharmaceutical protein purification.
Shi L; Chen Q; Norling LA; Lau AS; Krejci S; Xu Y
Biotechnol Bioeng; 2004 Sep; 87(7):884-96. PubMed ID: 15334415
[TBL] [Abstract][Full Text] [Related]
5. Limits in virus filtration capability? Impact of virus quality and spike level on virus removal with xenotropic murine leukemia virus.
Roush DJ; Myrold A; Burnham MS; And JV; Hughes JV
Biotechnol Prog; 2015; 31(1):135-44. PubMed ID: 25395156
[TBL] [Abstract][Full Text] [Related]
6. Comparison of filtration properties of hepatitis B virus, hepatitis C virus and simian virus 40 using a polyvinylidene fluoride membrane filter.
Oshima KH; Evans-Strickfaden T; Highsmith A
Vox Sang; 1998; 75(3):181-8. PubMed ID: 9852404
[TBL] [Abstract][Full Text] [Related]
7. Validation of removal of human retroviruses.
Marcus-Sekura CJ
Dev Biol Stand; 1991; 75():133-43. PubMed ID: 1794615
[TBL] [Abstract][Full Text] [Related]
8. Virus filtration of high-concentration monoclonal antibody solutions.
Marques BF; Roush DJ; Göklen KE
Biotechnol Prog; 2009; 25(2):483-91. PubMed ID: 19353736
[TBL] [Abstract][Full Text] [Related]
9. Virus retention by a hydrophilic triple-layer PVDF microporous membrane filter.
Aranha-Creado H; Oshima K; Jafari S; Howard G; Brandwein H
PDA J Pharm Sci Technol; 1997; 51(3):119-24. PubMed ID: 9203825
[TBL] [Abstract][Full Text] [Related]
10. Improvement of virus safety of an antihemophilc factor IX by virus filtration process.
Kim IS; Choi YW; Kang Y; Sung HM; Sohn KW; Kim YS
J Microbiol Biotechnol; 2008 Jul; 18(7):1317-25. PubMed ID: 18667862
[TBL] [Abstract][Full Text] [Related]
11. A comparison of methods for the estimation of retroviral burden.
Bierley ST; Raineri R; Poiley JA; Morgan EM
Dev Biol Stand; 1996; 88():163-5. PubMed ID: 9119132
[TBL] [Abstract][Full Text] [Related]
12. Evaluation and validation of virus removal by ultrafiltration during the production of diaspirin crosslinked haemoglobin (DCLHb).
Azari M; Boose JA; Burhop KE; Camacho T; Catarello J; Darling A; Ebeling AA; Estep TN; Pearson L; Guzder S; Herren J; Ogle K; Paine J; Rohn K; Sarajari R; Sun CS; Zhang L
Biologicals; 2000 Jun; 28(2):81-94. PubMed ID: 10885615
[TBL] [Abstract][Full Text] [Related]
13. Process scale considerations in evaluation studies and scale-up.
Walter JK; Werz W; Berthold W
Dev Biol Stand; 1996; 88():99-108. PubMed ID: 9119169
[TBL] [Abstract][Full Text] [Related]
14. Cumulative viral titer reduction demonstrated by sequential challenge of a tangential flow membrane filtration system and a direct flow pleated filter cartridge.
Aranha-Creado H; Fennington GJ
PDA J Pharm Sci Technol; 1997; 51(5):208-12. PubMed ID: 9357307
[TBL] [Abstract][Full Text] [Related]
15. Improved removal of viruslike particles from purified monoclonal antibody IgM preparation via virus filtration.
Maerz H; Hahn SO; Maassen A; Meisel H; Roggenbuck D; Sato T; Tanzmann H; Emmrich F; Marx U
Nat Biotechnol; 1996 May; 14(5):651-2. PubMed ID: 9630961
[No Abstract] [Full Text] [Related]
16. Efficient removal of viruses by a novel polyvinylidene fluoride membrane filter.
Roberts P
J Virol Methods; 1997 Apr; 65(1):27-31. PubMed ID: 9128859
[TBL] [Abstract][Full Text] [Related]
17. Removal of xenotropic murine leukemia virus by nanocellulose based filter paper.
Asper M; Hanrieder T; Quellmalz A; Mihranyan A
Biologicals; 2015 Nov; 43(6):452-6. PubMed ID: 26328471
[TBL] [Abstract][Full Text] [Related]
18. Removal of TSE agents by depth or membrane filtration from plasma products.
Roberts PL; Evans D; Harris L
Biologicals; 2010 Jan; 38(1):158-61. PubMed ID: 19854662
[TBL] [Abstract][Full Text] [Related]
19. Validation of retroviral detection for rodent cell-derived products and gene therapy applications.
Hughes JV; Messner K; Burnham M; Patel D; White EM
Dev Biol Stand; 1996; 88():297-304. PubMed ID: 9119153
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of viral removal by nanofiltration using real-time quantitative polymerase chain reaction.
Zhao X; Bailey MR; Emery WR; Lambooy PK; Chen D
Biotechnol Appl Biochem; 2007 Jun; 47(Pt 2):97-104. PubMed ID: 17233631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
